|
"shang ju wu"的相关文件
显示项目 6-15 / 85 (共9页)
1 2 3 4 5 6 7 8 9 > >>
每页显示[10|25|50]项目
| 臺大學術典藏 |
2022-03-04T03:55:35Z |
Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remission
|
TIEN FENG-MING; Tsai, Cheng-Hong; Huang, Sheng-Chuan; LIU JIA-HAU; Chen, Chien-Yuan; Kuo, Yuan-Yeh; Chuang, Yi-Kuang; Tseng, Mei-Hsuan; Peng, Yen-Ling; Liu, Ming-Chih; Liu, Chia-Wen; Liao, Xiu-Wen; Lin, Liang-In; Wu, Yu-Sin; Hou, Mei-Fang; SHANG-JU WU; SZU-CHUN HSU; Ko, Bor-Sheng; Chou, Wen-Chien; MING YAO; Hou, Hsin-An; Tang, Jih-Luh; Tien, Hwei-Fang |
| 臺大學術典藏 |
2022-03-04T03:52:50Z |
Polatuzumab vedotin-based salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience
|
Wang, Yu-Wen; Tsai, Xavier Cheng-Hong; Hou, Hsin-An; TIEN FENG-MING; LIU JIA-HAU; Chou, Wen-Chien; Ko, Bor-Sheng; Chen, Yu-Wen; Lin, Chien-Chin; Cheng, Chieh-Lung; Lo, Min-Yen; LIN YUN-CHU; Lu, Li-Chun; SHANG-JU WU; Kuo, Sung-Hsin; Hong, Ruey-Long; Huang, Tai-Chung; MING YAO |
| 臺大學術典藏 |
2022-03-04T03:51:18Z |
Bone marrow plasma level of decorin may be associated with improved treatment outcomes in a subset of multiple myeloma patients
|
Huang, Shang-Yi; Lin, Hsiu-Hsia; MING YAO; Tang, Jih-Luh; SHANG-JU WU; Chou, Wen-Chien; SZU-CHUN HSU; Ko, Bor-Sheng; Tien, Hwei-Fang |
| 臺大學術典藏 |
2021-11-21T23:19:44Z |
Polatuzumab vedotin–based salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience
|
Wang, Yu Wen; Tsai, Xavier Cheng Hong; HSIN-AN HOU; Tien, Feng Ming; Liu, Jia Hau; WEN-CHIEN CHOU; BOR-SHENG KO; YU-WEN CHEN; CHIEN-CHIN LIN; Cheng, Chieh Lung; Lo, Min Yen; Lin, Yun Chu; Lu, Li Chun; SHANG-JU WU; SUNG-HSIN KUO; Hong, Ruey Long; TAI-CHUNG HUANG; MING YAO |
| 臺大學術典藏 |
2021-11-21T23:19:35Z |
Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remission
|
Tien, Feng Ming; CHENG-HONG TSAI; Huang, Sheng Chuan; Liu, Jia Hau; Chen, Chien-Yuan; YUAN-YEH KUO; Chuang, Yi Kuang; Tseng, Mei Hsuan; Peng, Yen Ling; Liu, Ming Chih; CHIA-WEN LIU; Liao, Xiu Wen; LIANG-IN LIN; Wu, Yu Sin; Hou, Mei Fang; SHANG-JU WU; SZU-CHUN HSU; BOR-SHENG KO; WEN-CHIEN CHOU; MING YAO; HSIN-AN HOU; JIH-LUH TANG; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-08-15T00:07:56Z |
Bone marrow plasma level of decorin may be associated with improved treatment outcomes in a subset of multiple myeloma patients
|
SHANG-YI HUANG; Lin, Hsiu Hsia; MING YAO; JIH-LUH TANG; SHANG-JU WU; WEN-CHIEN CHOU; SZU-CHUN HSU; BOR-SHENG KO; HWEI-FANG TIEN |
| 臺大學術典藏 |
2021-01-05T00:56:44Z |
Nucleophosmin mutations in de novo acute myeloid leukemia: The age-dependent incidences and the stability during disease evolution
|
Tseng M.-H.; Chiou R.-J.; Huang C.-F.; SHANG-JU WU; Chen C.-Y.; Chou W.-C.; Tang J.-L.; Lin L.-I.; Yao M.; Tsay W.; Lin D.-T.; Lin K.-H.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-05T00:56:42Z |
Acute myeloid leukemia bearing t(7;11)(p15;p15) is a distinct cytogenetic entity with poor outcome and a distinct mutation profile: Comparative analysis of 493 adult patients
|
Hsu S.-C.; Huang S.-Y.; SHANG-JU WU; Ko B.-S.; Tsay W.; Chou W.-C.; Chen C.-Y.; Hou H.-A.; Lin L.-I.; Tang J.-L.; Yao M.; Chen Y.-C.; Huang Y.-N.; Tseng M.-H.; Huang C.-F.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-05T00:56:42Z |
Clinical characteristics and treatment response of Hodgkin's lymphoma in Taiwan
|
SHANG-JU WU; Tien H.-F.; Wang C.-H.; Chen C.-Y.; Su I.-J.; Tang J.-L.; Chou W.-C.; Ko B.-S.; Huang S.-Y.; Yao M.; Tsay W.; Chen Y.-C. |
| 臺大學術典藏 |
2021-01-05T00:56:41Z |
EBV-positive Hodgkin lymphoma is associated with suppression of p21cip1/waf1and a worse prognosis
|
Liu T.-Y.; SHANG-JU WU; Huang M.-H.; Lo F.-Y.; Tsai M.-H.; Tsai C.-H.; Hsu S.-M.; Lin C.-W. |
显示项目 6-15 / 85 (共9页)
1 2 3 4 5 6 7 8 9 > >>
每页显示[10|25|50]项目
|
